182 related articles for article (PubMed ID: 2718887)
1. [Monoclonal anti-HIV antibodies in HIV/AIDS research. Diagnosis and therapy].
Giese R; Grunow R
Allerg Immunol (Leipz); 1989; 35(1):25-37. PubMed ID: 2718887
[TBL] [Abstract][Full Text] [Related]
2. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
Cohen J
Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
[No Abstract] [Full Text] [Related]
3. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS.
Tenner-Rácz K; Rácz P; Dietrich M; Kern P; Janossy G; Veronese-Dimarzo F; Klatzmann D; Gluckman JC; Popovic M
AIDS; 1987 Jul; 1(2):95-104. PubMed ID: 3130085
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus.
Evans LA; Homsy JM; Morrow WJ; Gaston I; Sooy CD; Levy JA
J Immunol; 1988 Feb; 140(3):941-3. PubMed ID: 2828474
[TBL] [Abstract][Full Text] [Related]
7. Current status of the development of an AIDS vaccine.
Lasky LA
Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
[TBL] [Abstract][Full Text] [Related]
8. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
9. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
11. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
[TBL] [Abstract][Full Text] [Related]
12. An anti-HIV-1 gag protein rat monoclonal antibody library.
Bodéus M; Heusterspreute M; Hirsch F; Benarous R; Bazin H; Burtonboy G
Virus Res; 1995 Nov; 39(1):35-46. PubMed ID: 8607282
[TBL] [Abstract][Full Text] [Related]
13. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
[No Abstract] [Full Text] [Related]
14. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag.
Tersmette M; Winkel IN; Groenink M; Gruters RA; Spence RP; Saman E; Van Der Groen G; Miedema F; Huisman JG
Virology; 1989 Jul; 171(1):149-55. PubMed ID: 2472701
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV
Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245
[TBL] [Abstract][Full Text] [Related]
16. Virologic and serologic aspects of human immunodeficiency virus infection in infants and children.
Andiman WA
Semin Perinatol; 1989 Feb; 13(1):16-26. PubMed ID: 2645655
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies directed against human immunodeficiency virus (HIV) gag proteins with specificity for conserved epitopes in HIV-1, HIV-2 and simian immunodeficiency virus.
Niedrig M; Rabanus JP; L'Age Stehr J; Gelderblom HR; Pauli G
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2109-14. PubMed ID: 2457067
[TBL] [Abstract][Full Text] [Related]
18. Prospects for a human immunodeficiency virus/AIDS vaccine.
Murphy FA; Folks TM; Lairmore MD
Dev Biol Stand; 1990; 72():3-15. PubMed ID: 1704324
[No Abstract] [Full Text] [Related]
19. Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide.
Zhou EM; Chanh TC; Dreesman GR; Kanda P; Kennedy RC
J Immunol; 1987 Nov; 139(9):2950-6. PubMed ID: 3668251
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
Papsidero LD; Poiesz BJ; Montagna RA
Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
